Personal information

Websites & social links

http://ua.hggm.es
http://www.iisgm.com
http://www.cibersam.es

Other IDs

Scopus Author ID: 56208998400
ResearcherID: X-8877-2018

Keywords

neurodevelopmental disorders, early-onset psychosis, schizophrenia, prevention, high-risk populations, genetics, risk factors

Countries

Spain

Biography

Medical Doctor (2005), Specialist in Psychiatry (2011), PhD in Medicine (2019), with specific training in psychosis and high-risk populations in Spain, Germany, and the UK. Psychiatrist at the Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón (HGUGM), Health Research Institute Gregorio Marañón (Instituto de Investigación Sanitaria Gregorio Marañón; IiSGM), Spanish Network for Research in Mental Health (CIBER de Salud Mental; CIBERSAM), since June 2011. Current clinical activity in the specific outpatient clinic for people at genetic and clinical high risk for psychosis and other mental disorders. Areas of expertise: assessment, diagnosis and intervention in psychosis and high-risk populations, coordination and implementation of multicentre research projects and clinical trials in these populations. Main areas of scientific interest: psychotic disorders, high-risk populations, preventive interventions, and developmental neuropsychopharmacology, with participation in more than 80 related publications and more than 25 research projects in the past ten years. Coordinator of the research unit at the Institute of Psychiatry and Mental Health at Hospital Gregorio Marañón since June 2014. Co-principal Investigator of CIBERSAM group CB/07/09/0023 since 2017.

Activities

Collapse all

Employment (1)

Department of Child and Adolescent Psychiatry. Institute of Psychiatry and Mental Health. Hospital General Universitario Gregorio Marañón. Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM). CIBERSAM. School of Medicine, Universidad Complutense: Madrid, ES

2011-06-01 to present | Psychiatrist. Postdoctoral Fellow. Research Coordinator.
Employment
Source: Self-asserted source
Covadonga M. Díaz-Caneja

Education and qualifications (3)

Universidad Complutense de Madrid: Madrid, Comunidad de Madrid, ES

2016-10 to 2019-02 | PhD in Medicine
Education
Source: Self-asserted source
Covadonga M. Díaz-Caneja

Hospital General Universitario Gregorio Marañón: Madrid, Madrid, ES

2007-05 to 2011-05 | Specialist in Psychiatry
Qualification
Source: Self-asserted source
Covadonga M. Díaz-Caneja

Universidad Complutense de Madrid: Madrid, Comunidad de Madrid, ES

1999-09 to 2005-06 | Degree in Medicine and Surgery (MD)
Education
Source: Self-asserted source
Covadonga M. Díaz-Caneja

Professional activities (31)

Regional Society for Psychiatry: Madrid, ES

2021-06 to present | Member of the Executive Committee
Service
Source: Self-asserted source
Covadonga M. Díaz-Caneja

European Neuropsychopharmacology: Utrecht, NL

2021-03 to present | Member of the Editorial Board
Service
Source: Self-asserted source
Covadonga M. Díaz-Caneja

Asociación Española de Psiquiatría del Niño y el Adolescente: A Coruña, ES

2021-03 to present | Member of the Scientific Advisory Board
Service
Source: Self-asserted source
Covadonga M. Díaz-Caneja

Spanish Society for Biological Psychiatry: Madrid, ES

2020-09 to present
Membership
Source: Self-asserted source
Covadonga M. Díaz-Caneja

Asociación de Científicos Alicia Koplowitz: Madrid, ES

2020-05 to present
Membership
Source: Self-asserted source
Covadonga M. Díaz-Caneja

Schizophrenia International Research Society: Brentwood, TN, US

2019-11 to present
Membership
Source: Self-asserted source
Covadonga M. Díaz-Caneja

Spanish Society for Psychiatry: Madrid, ES

2019-09 to present
Membership
Source: Self-asserted source
Covadonga M. Díaz-Caneja

International Early Psychosis Association- Early Intervention in Mental Health: Parkville, VIC, AU

2019-09 to present
Membership
Source: Self-asserted source
Covadonga M. Díaz-Caneja

Revista de Psiquiatría Infanto-Juvenil: Madrid, ES

2019-03 to present | Member of the Editorial Board
Service
Source: Self-asserted source
Covadonga M. Díaz-Caneja

Centro de Investigación Biomédica en Red de Salud Mental: Madrid, Madrid, ES

2017 to present | Co-Principal Investigator
Service
Source: Self-asserted source
Covadonga M. Díaz-Caneja

Asociación Española de Psiquiatría del Niño y el Adolescente: A Coruña, ES

2013-05 to present
Membership
Source: Self-asserted source
Covadonga M. Díaz-Caneja

Centro de Investigación Biomédica en Red de Salud Mental: Madrid, Madrid, ES

2012-09 to present
Membership
Source: Self-asserted source
Covadonga M. Díaz-Caneja

Ambiente y Genes en Esquizofrenia- Grupos de Investigación en la Comunidad de Madrid: Madrid, ES

2012-09 to present
Membership
Source: Self-asserted source
Covadonga M. Díaz-Caneja

European College of Neuropsychopharmacology: Utrecht, Utrecht, NL

2012-03 to present
Membership
Source: Self-asserted source
Covadonga M. Díaz-Caneja

International Association of Youth Mental Health: Victoria, AU

2012 to present
Membership
Source: Self-asserted source
Covadonga M. Díaz-Caneja

Schizophrenia International Research Society: Brentwood, TN, US

2022-04 | Early Career Award
Distinction
Source: Self-asserted source
Covadonga M. Díaz-Caneja

European College of Neuropsychopharmacology: Utrecht, Utrecht, NL

2021-10 | ECNP Rising Star Award
Distinction
Source: Self-asserted source
Covadonga M. Díaz-Caneja

European Psychiatric Association: Strasbourg, FR

2021-03 | EPA Research Prize
Distinction
Source: Self-asserted source
Covadonga M. Díaz-Caneja

Spanish Society for Biological Psychiatry: Madrid, ES

2020-10 | Young Investigator Award
Distinction
Source: Self-asserted source
Covadonga M. Díaz-Caneja

Universidad Complutense de Madrid: Madrid, Comunidad de Madrid, ES

2020-09 | PhD Extraordinary Award in Medicine
Distinction
Source: Self-asserted source
Covadonga M. Díaz-Caneja

European Psychiatric Association: Strasbourg, FR

2020-07 | EPA Research Prize
Distinction
Source: Self-asserted source
Covadonga M. Díaz-Caneja

European College of Neuropsychopharmacology: Utrecht, Utrecht, NL

2013 to 2017 | Member of the Junior Advisory Panel
Service
Source: Self-asserted source
Covadonga M. Díaz-Caneja

Schizophrenia International Research Society: Brentwood, TN, US

2015-04 | Young Investigator Award
Distinction
Source: Self-asserted source
Covadonga M. Díaz-Caneja

European College of Neuropsychopharmacology: Utrecht, NL

2014-09 | ECNP Travel Award
Distinction
Source: Self-asserted source
Covadonga M. Díaz-Caneja

European Psychiatric Association: Strasbourg, FR

2014-04 | Travel Award
Distinction
Source: Self-asserted source
Covadonga M. Díaz-Caneja

King's College London: London, London, GB

2013-07 to 2013-12 | Honorary Visiting Researcher (Institute of Psychiatry, Psychology, and Neuroscience)
Invited position
Source: Self-asserted source
Covadonga M. Díaz-Caneja

Volkswagen Foundation: Hanover, DE

2013-04 | Travel Grant
Distinction
Source: Self-asserted source
Covadonga M. Díaz-Caneja

European College of Neuropsychopharmacology: Utrecht, Utrecht, NL

2012-09 | ECNP Travel Award
Distinction
Source: Self-asserted source
Covadonga M. Díaz-Caneja

The International Association for Child and Adolescent Psychiatry and Allied Professions: Geneva, CH

2012-07 | Donald J. Cohen Fellowship
Distinction
Source: Self-asserted source
Covadonga M. Díaz-Caneja

Ernesto Seco Foundation: Madrid, ES

2005-06 | Fellowship
Distinction
Source: Self-asserted source
Covadonga M. Díaz-Caneja

Consejo Superior de Investigaciones Científicas: Madrid, Madrid, ES

2004 | Research fellowship
Distinction
Source: Self-asserted source
Covadonga M. Díaz-Caneja

Funding (31)

Dissecting the clinical and biological heterogeneity of first-episode psychosis: a longitudinal study in a representative cohort

2021-01 to 2023-12 | Grant
Instituto de Salud Carlos III (Madrid, ES)
GRANT_NUMBER:

PI20/00721
Source: Self-asserted source
Covadonga M. Díaz-Caneja

Cellular aging associated with early exposure to stressful life events in 22q11.2 deletion syndrome

2021 to 2022 | Grant
Instituto de Salud Carlos III (Madrid, ES)
GRANT_NUMBER:

PI17/00481
Source: Self-asserted source
Covadonga M. Díaz-Caneja

Juan Rodés Fellowship

2020-01 to 2024-01 | Salary award
Instituto de Salud Carlos III (Madrid, ES)
GRANT_NUMBER:

JR19/00024
Source: Self-asserted source
Covadonga M. Díaz-Caneja

Psychosis-Risk Outcomes Network (ProNET) (Site Co-Principal Investigator)

2020 to 2024 | Award
National Institutes of Health (Md., Md., US)
GRANT_NUMBER:

1U01MH124639-01
Source: Self-asserted source
Covadonga M. Díaz-Caneja

Phenotypic characterization and association with genetic variables in Jacobsen syndrome (11q- or 11q deletion)

2019 to 2020 | Contract
11q Association (Madrid, ES)
GRANT_NUMBER:

FIBHGM-CCA005-2019
Source: Self-asserted source
Covadonga M. Díaz-Caneja

Autism Innovative Medicine Studies – 2 – Trials (Co-Investigator)

2018 to 2023 | Grant
European Commission (Brussels, BE)
URL: https://www.aims-2-trials.eu/
GRANT_NUMBER: 777394-2 AIMS-2-TRIALS
Source: Self-asserted source
Covadonga M. Díaz-Caneja

Differential profiles and influence of traumatic experiences and biological variables on psychosis development in young people with at-risk mental states: An observational study (Co-Investigator)

2018 to 2022 | Grant
Instituto de Salud Carlos III (Madrid, ES)
GRANT_NUMBER:

PI17/00997
Source: Self-asserted source
Covadonga M. Díaz-Caneja

Gene and Environment in Schizophrenia- Research Groups in Madrid (AGES 2-CM) (Co-Investigator)

2018 to 2022 | Grant
Consejería de Educación e Investigación (Madrid, ES)
GRANT_NUMBER: B2017/BMD- 3740
Source: Self-asserted source
Covadonga M. Díaz-Caneja

Prognostic factors and developmental trajectories in early-onset bipolar disorder: A five-year follow-up longitudinal study (Co-Investigator)

2018 to 2022 | Grant
Instituto de Salud Carlos III (Madrid, ES)
GRANT_NUMBER:

PI17/02227
Source: Self-asserted source
Covadonga M. Díaz-Caneja

Study of the ethipathophysiological mechanisms underpinning progressive gray matter loss in children and adolescents with first episode psychosis, at risk mental states and healthy controls (Co-Investigator)

2018 to 2022 | Contract
Fundación Familia Alonso (Madrid, ES)
GRANT_NUMBER:

FIBHGM-CCA004-2018
Source: Self-asserted source
Covadonga M. Díaz-Caneja

Effect of a 48-week course of N-acetylcysteine (NAC) as add-on treatment on gray matter loss and oxidative metabolism, symptoms and functioning in early-onset first-episode psychosis: a randomized, double-blind, placebo-controlled clinical trial (Co-Investigator)

2018 to 2021 | Award
Centro de Investigación Biomédica en Red de Salud Mental (Madrid, ES)
GRANT_NUMBER:

SAM18PI02
Source: Self-asserted source
Covadonga M. Díaz-Caneja

Evaluation of the efficacy of a preventative intervention on prevalence of bullying and health status in children and adolescents: Cluster-randomized trial (Co-Investigator)

2017 to 2020 | Grant
Instituto de Salud Carlos III (Madrid, ES)
GRANT_NUMBER:

PI16/02012
Source: Self-asserted source
Covadonga M. Díaz-Caneja

52-week extension study of pimavanserin for the adjunctive treatment in patients with schizophrenia (Co-Investigator)

2017 to 2019 | Contract
ACADIA Pharmaceuticals (CA, CA, US)
GRANT_NUMBER:

Eudra-CT: 2016-003435-38
Source: Self-asserted source
Covadonga M. Díaz-Caneja

Common and differential mechanisms involved in the ethiopathogenesis of early-onset bipolar disorder and major depressive disorder (Co-Investigator)

2017 to 2019 | Grant
Instituto de Salud Carlos III (Madrid, ES)
GRANT_NUMBER:

PI14/02069
Source: Self-asserted source
Covadonga M. Díaz-Caneja

Phase II double-blind, placebo-controlled trial to assess the efficacy and safety of pimavanserin for the adjunctive treatment of negative symptoms in patients with schizophrenia (Co-Investigator)

2017 to 2019 | Contract
ACADIA Pharmaceuticals (CA, CA, US)
GRANT_NUMBER:

Eudra-CT: 2016-003436-20
Source: Self-asserted source
Covadonga M. Díaz-Caneja

Placebo-controlled trial in subjects at Ultra-high Risk for Psychosis with Omega-3 fatty acidS in Europe

2016 to 2021 | Contract
University Medical Center Utrecht (Utrecht, NL)
GRANT_NUMBER:

ABR54654
Source: Self-asserted source
Covadonga M. Díaz-Caneja

Psychiatric Ratings using Intermediate Stratified Markers (PRISM): Providing quantitative biological measures to facilitate the discovery and development of new treatments for social and cognitive deficits in Alzheimer’s disease, schizophrenia and depression (Co-Investigator)

2016 to 2018 | Grant
European Commission (Brussels, BE)
GRANT_NUMBER: IMI2-H2020-JTI-115916
Source: Self-asserted source
Covadonga M. Díaz-Caneja

Cellular aging in first episodes of early-onset psychosis (Co-Investigator)

2015 to 2017 | Grant
Instituto de Salud Carlos III (Madrid, ES)
GRANT_NUMBER:

PI14/00397
Source: Self-asserted source
Covadonga M. Díaz-Caneja

Understanding obesity, metabolic syndrome, type 2 diabetes and fatty liver disease: a multidisciplinary approach (Co-Investigator)

2015 to 2017 | Grant
Instituto de Salud Carlos III (Madrid, ES)
GRANT_NUMBER:

PIE14/00031
Source: Self-asserted source
Covadonga M. Díaz-Caneja

European Long Acting Antipsychotics in Schizophrenia Trial.

2014 to 2019 | Contract
European Group for Research in Schizophrenia (Utrecht, NL)
GRANT_NUMBER:

ABR49490
Source: Self-asserted source
Covadonga M. Díaz-Caneja

Visiting Fellowship

2013-07 to 2013-12 | Award
Fundación Alicia Koplowitz (Madrid, ES)
Source: Self-asserted source
Covadonga M. Díaz-Caneja

Translating neuroimaging findings from research into clinical practice (PSYSCAN) (Co-Investigator)

2013 to 2021 | Grant
European Commission (Brussels, BE)
URL: http://psyscan.eu/
GRANT_NUMBER: FP7- HEALTH-2013-2.2.1-2-603196
Source: Self-asserted source
Covadonga M. Díaz-Caneja

Neuroimaging platform for characterisation of metabolic co-morbidities in psychotic disorders (Co-Investigator)

2013 to 2018 | Grant
European Commission (Brussels, BE)
GRANT_NUMBER: FP7- HEALTH.2013. 2.2.1-2-602478
Source: Self-asserted source
Covadonga M. Díaz-Caneja

Neurobiology of gray matter loss in first episodes of early-onset psychosis (Co-Investigator)

2013 to 2016 | Grant
Instituto de Salud Carlos III (Madrid, ES)
GRANT_NUMBER:

PI12/01303
Source: Self-asserted source
Covadonga M. Díaz-Caneja

Effect of a 48-week course of N-acetylcysteine (NAC) as add-on treatment on gray matter loss and oxidative metabolism, symptoms and functioning in early-onset first-episode psychosis: a randomized, double-blind, placebo-controlled clinical trial (Co-Investigator)

2013 to 2014 | Award
Centro de Investigación Biomédica en Red de Salud Mental (Madrid, ES)
GRANT_NUMBER:

13CINT1
Source: Self-asserted source
Covadonga M. Díaz-Caneja

Río Hortega Fellowship

2012-01 to 2013-12 | Salary award
Instituto de Salud Carlos III (Madrid, ES)
GRANT_NUMBER:

CM11/00207
Source: Self-asserted source
Covadonga M. Díaz-Caneja

Biological mechanisms involved in the neuroprotection with omega-3 fatty acids grasos omega-3 (Co-Investigator)

2012 to 2015 | Grant
Fundación Alicia Koplowitz (Madrid, ES)
GRANT_NUMBER:

FAK2012
Source: Self-asserted source
Covadonga M. Díaz-Caneja

Effect of 24-week treatment with omega-3 fatty acids on gray matter loss at one year and oxidative metabolism in patients with first episodes of early onset psychosis: Double-blind, placebo-controlled randomized clinical trial (Co-Investigator)

2012 to 2015 | Grant
Ministerio de Sanidad, Política Social e Igualdad (Madrid, ES)
GRANT_NUMBER:

EC11-093
Source: Self-asserted source
Covadonga M. Díaz-Caneja

Neurocognitive anomalies in the pathogeny of paranoia (delusional disorder) (Co-Investigator)

2012 to 2014 | Grant
Instituto de Salud Carlos III (Madrid, ES)
GRANT_NUMBER:

PI11/02849
Source: Self-asserted source
Covadonga M. Díaz-Caneja

5. Optimization of Treatment and Management of Schizophrenia in Europe (OPTiMiSE). Large Scale Integrating Project (Co-Investigator)

2010 to 2016 | Grant
European Commission (Brussels, BE)
GRANT_NUMBER: HEALTH-2009-2.2.1-3.-242114
Source: Self-asserted source
Covadonga M. Díaz-Caneja

Identification of neurocognitive anomalies involved in the development and maintenance of delusional beliefs in delusional disorder (paranoia) (Co-Investigator)

2009 to 2011 | Grant
Fundación Mutua Madrileña (Madrid, ES)
GRANT_NUMBER:

FMM2009/02
Source: Self-asserted source
Covadonga M. Díaz-Caneja

Peer review (9 reviews for 4 publications/grants)

Review activity for European child & adolescent psychiatry (1)
Review activity for Molecular psychiatry. (1)
Review activity for The European journal of psychiatry. (6)
Review activity for Translational psychiatry. (1)
How many people are using ORCID?